Search clinical trials for: Ph CML
Total 255215 results
-
Novartis PharmaceuticalsCompletedChronic Myelogenous Leukemia in Chronic PhaseUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedLeukemia | Chronic Myelogenous LeukemiaUnited States
-
Memorial Sloan Kettering Cancer CenterCompletedLeukemia | Non-Hodgkin's Lymphoma | Myelodysplastic Syndrome | Allogeneic Marrow TransplantUnited States
-
M.D. Anderson Cancer CenterNovartis PharmaceuticalsCompleted
-
King Faisal Specialist Hospital & Research CenterCompleted
-
M.D. Anderson Cancer CenterCephalonTerminatedChronic Myeloid LeukemiaUnited States
-
M.D. Anderson Cancer CenterSchering-PloughCompletedChronic Myeloid LeukemiaUnited States
-
Novartis PharmaceuticalsCompletedChronic Myelogenous LeukemiaChina, Argentina, Russian Federation, Germany, Guatemala, Panama, Colombia, Mexico, Brazil, India, Poland, Venezuela
-
M.D. Anderson Cancer CenterGenzyme, a Sanofi CompanyCompletedChronic Myelomonocytic Leukemia | Myelodysplastic SyndromeUnited States
-
Merck Sharp & Dohme LLCTerminatedBlast Phase Philadelphia Chromosomes Positive (Ph+) Chronic Myelogenous Leukemia (CML) | Philadelphia Chromosome Positive (Ph+) Acute Lymphocytic Leukemia (ALL)
-
Kanto CML Study GroupEpidemiological and Clinical Research Information NetworkCompleted
-
Kanto CML Study GroupEpidemiological and Clinical Research Information NetworkCompletedChronic Myeloid LeukemiaJapan
-
Indiana University School of MedicineTerminatedMyelodysplastic Syndromes | Leukemia, Myeloid, Acute | Leukemia, Lymphoid | Leukemia, Myelogenous, ChronicUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Withdrawn
-
Jiangsu Hansoh Pharmaceutical Co., Ltd.UnknownChronic Myelogenous LeukemiaChina
-
Eurofarma Laboratorios S.A.Withdrawn
-
Bristol-Myers SquibbCompletedChronic Myeloid Leukemia (CML)United States
-
M.D. Anderson Cancer CenterMerck Sharp & Dohme LLCCompletedHematologic Diseases | Myelodysplastic Syndrome | Acute Myelogenous Leukemia | Chronic Myelogenous LeukemiaUnited States
-
University of LeipzigCompletedLeukemia, Myelogenous, Chronic, BCR-ABL Positive
-
Otsuka Pharmaceutical Co., Ltd.CompletedAcute Myeloid Leukemia | Multiple Myeloma | Non-Hodgkin Lymphoma | Chronic Myeloid Leukemia | Acute Lymphoid LeukemiaJapan
-
University of Massachusetts, WorcesterTerminatedChronic Myelogenous LeukemiaUnited States
-
M.D. Anderson Cancer CenterCompletedLeukemia | Myelodysplastic SyndromeUnited States
-
Threshold PharmaceuticalsCompletedAcute Lymphoblastic Leukemia | Chronic Lymphocytic Leukemia | Acute Myelogenous Leukemia | Chronic Myelogenous Leukemia | High-risk Myelodysplastic Syndrome | Advanced MyelofibrosisUnited States
-
Novartis PharmaceuticalsCompleted
-
M.D. Anderson Cancer CenterTerminated
-
Novartis PharmaceuticalsCompletedAll Indications for Glivec/Gleevec and TasignaUnited States
-
Infinity Pharmaceuticals, Inc.Terminated
-
University of TexasCompletedAcute Lymphocytic Leukemia | Acute Myelogenous Leukemia | Chronic Myelogenous Leukemia
-
Ginna LaportTerminatedAcute Myelogenous Leukemia (AML) - Relapsed, Primary Refractory Disease or Poor Risk Factors | Chronic Myelogenous Leukemia (CML) - Accelerated or Second Chronic Phase | Myelodysplastic Syndrome (MDS) - High and Intermediate Risk | Non-Hodgkin's Lymphoma (NHL) | Chronic Lymphocytic Leukemia...United States
-
Arbeitsgemeinschaft medikamentoese TumortherapieCelgene CorporationUnknownChronic Myelomonocytic LeukemiaAustria
-
Sidney Kimmel Comprehensive Cancer Center at Johns...M.D. Anderson Cancer Center; Fred Hutchinson Cancer Center; Otsuka Pharmaceutical...CompletedLymphoma | Leukemia | Multiple Myeloma | Myelodysplastic SyndromeUnited States
-
Merck Sharp & Dohme LLCTerminatedChronic Myelogenous Leukemia | Leukemia, Lymphoblastic, Acute, Philadelphia-Positive
-
Merck Sharp & Dohme LLCTerminated
-
ChemGenex PharmaceuticalsTerminatedMyeloid Leukemia, Chronic, Chronic-Phase | Myeloid Leukemia, Chronic | Myeloid Leukemia, Chronic, Accelerated-Phase | Blast PhaseUnited States
-
BayerCompletedChronic Myelogenous LeukemiaUnited States, France
-
Università degli Studi di BresciaCompleted
-
Ariad PharmaceuticalsTerminatedChronic Myeloid LeukemiaUnited States, Australia, Austria, Belgium, Canada, Czech Republic, Finland, France, Germany, Hong Kong, Italy, Korea, Republic of, Netherlands, New Zealand, Poland, Portugal, Puerto Rico, Singapore, Slovakia, Spain, Sweden, Switz... and more
-
Bristol-Myers SquibbCompletedLeukemia, Lymphoblastic, Acute, Philadelphia-Positive | Myeloid Leukemia, Chronic, Accelerated PhaseAustralia, Canada, France, Germany, Italy, Korea, Republic of, Taiwan, Thailand, United States, Spain, Austria, Denmark, Belgium, Sweden, Switzerland, Netherlands, Peru, South Africa, Philippines, Singapore, Russian Federation, Br... and more
-
Dong-A ST Co., Ltd.CompletedChronic Myeloid Leukemia | Gastrointestinal Stromal TumorKorea, Republic of
-
Synta Pharmaceuticals Corp.CompletedAcute Myeloid Leukemia | Acute Lymphoblastic Leukemia | AML | CML | ALL | Blast-phase Chronic Myelogenous LeukemiaUnited States
-
Synta Pharmaceuticals Corp.CompletedMyeloproliferative Disorders | AML | MDS | CMLUnited States
-
PfizerCompletedSmoking CessationUnited States, Taiwan, Australia, Germany, Egypt, United Kingdom, Canada, Czech Republic, Mexico, Japan
-
Hospices Civils de LyonNovartisUnknownChronic Myeloid LeukemiaFrance
-
Deciphera Pharmaceuticals LLCCompletedChronic Myeloid LeukemiaUnited States
-
National Heart, Lung, and Blood Institute (NHLBI)CompletedMyelodysplastic Syndrome | Acute Myeloid Leukemia (AML) | Chronic Myeloid Leukemia (CML)United States
-
M.D. Anderson Cancer CenterAbiogen PharmaTerminatedChronic Myelogenous LeukemiaUnited States
-
H. Lee Moffitt Cancer Center and Research InstituteNovartisCompleted
-
M.D. Anderson Cancer CenterAccess Pharmaceuticals, Inc.Completed
-
Australasian Leukaemia and Lymphoma GroupMerck Sharp & Dohme LLC; Novartis PharmaceuticalsUnknownChronic Myeloid LeukaemiaAustralia
-
GlaxoSmithKlineCompletedCancerUnited States, France, Germany, Belgium